David Shaw’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,000
Closed -$3.26M 4940
2024
Q1
$3.26M Hold
10,000
﹤0.01% 2241
2023
Q4
$1.91M Hold
10,000
﹤0.01% 2706
2023
Q3
$1.99M Buy
+10,000
New +$2.36M ﹤0.01% 2571
2023
Q1
Sell
-10,900
Closed -$2.24M 4995
2022
Q4
$2.24M Sell
10,900
-2,700
-20% -$683K ﹤0.01% 2843
2022
Q3
$3.78M Buy
+13,600
New +$3.46M ﹤0.01% 2392
2022
Q1
Sell
-20,000
Closed -$3.57M 6065
2021
Q4
$3.57M Buy
20,000
+4,100
+26% +$809K ﹤0.01% 2767
2021
Q3
$3.27M Buy
15,900
+5,900
+59% +$1.16M ﹤0.01% 2543
2021
Q2
$1.9M Buy
+10,000
New +$1.64M ﹤0.01% 2993
2020
Q3
Sell
-20,000
Closed -$947K 4249
2020
Q2
$947K Buy
+20,000
New +$824K ﹤0.01% 2982

Other funds holding SWAV

David Shaw's SWAV Position: Q1 2024 in Review

David Shaw sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,617 shares — an estimated $397K sold.

David Shaw first reported a position in SWAV in Q2 2020 and held it in 14 quarters. The position peaked at $38.8M in Q2 2021. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • David Shaw reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 1,617 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $397K.
  • David Shaw first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • David Shaw's Shockwave Medical, Inc. Common Stock position peaked at $38.8M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.